B Crip 1.25mg Tablet
By B Crip
Rx
10 Tablet in a Strip

Composition
Bromocriptine(1.25mg)

Manufacturer - Abbott
16th Floor, Godrej BKC, Plot – C, "G" Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India

Expires on or after
July, 2026

liver
Limited information is accessible regarding the safety of B Crip 1.25mg Tablet in individuals with liver conditions. It is important to consult your doctor for guidance when considering its use in such cases. It is recommended to exercise caution when using this medication in patients with liver issues.

kidney
Limited data indicates B Crip 1.25mg Tablet may be safe for kidney patients without requiring dose adjustment. Consult your doctor for guidance.

alcohol
Avoid consuming alcohol while taking B Crip 1.25mg Tablet as it is not safe to mix them.

driving
Caution should be exercised when driving while taking B Crip 1.25mg Tablet, as it may lead to dizziness or weakness caused by low blood pressure. Refrain from driving if experiencing these symptoms.

pregnancy
B Crip 1.25mg Tablet is considered safe in pregnancy. Animal studies show minimal adverse effects on the baby, but human data is limited.

breastfeeding
Caution - BreastFeeding B Crip 1.25mg Tablet is not recommended for use during breastfeeding as it may pass into breastmilk and potentially harm the baby. Additionally, it can suppress lactation.
Habit Forming | No |
Chemical Class | Ergolines |
Therapeutic Class | NEURO CNS |
Action Class | Dopamine agonists-Hyperprolactinemia |
₹80.37
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024